Data / Form D filings / Neuro-Kinesis Corp
Neuro-Kinesis Corp: Form D filings
Neuro-Kinesis Corp, a biotechnology company in Inglewood, CA, filed 4 Form D notices with the SEC between 2020 and 2026. The latest, on April 24, 2026, reports $51,000 sold of a $2 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10524 S. LA CIENEGA BLVD., Inglewood, CA, 90304
- Phone
- (310) 641-2700
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1814194
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | New notice | $2,000,000 | $51,000 | $1,949,000 | 5 | Apr 13, 2026 | sec.gov |
| Jul 16, 2021 | New notice | $400,000 | $400,000 | 1 | Jun 30, 2021 | sec.gov | |
| Jun 11, 2020 | New notice | $5,000,000 | $50,000 | $4,950,000 | 3 | Jun 1, 2020 | sec.gov |
| Jun 11, 2020 | New notice | $1,000,000 | $50,000 | $950,000 | 1 | Jun 5, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Josh Shachar | Executive Officer, Director | Executive Chairman, Chief Technology Officer |
| Dr. Thomas Chen, MD, PhD | Director | Director |
| Eli Gang | Executive Officer, Director | Director, Chief Electrophysiology Officer |
| CHRISTOPHER BISSELL | Executive Officer | CHIEF FINANCIAL OFFICER |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 20, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Neuro-Kinesis Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.